November 30, 2010 |
Many over-the-counter, liquid medications meant for children contain dosing instructions and measuring cups or droppers that rarely match each other and could confuse even the most careful parent or caretaker, according to a new study. This could easily lead to under- or over-dosing, with potentially dangerous consequences, researchers said. The study, released online Tuesday in the Journal of the American Medical Assn., examined popular liquid cough, cold, allergy and stomach medications as well as painkillers and fever reducers, all meant for children younger than 12. More than one-quarter of the 200 products examined failed to include a measuring device, such as cup, dropper or oral syringe.
CALIFORNIA | LOCAL
August 22, 1986
Dr. Bronow evades the serious issue of the day with respect to health care; that of cost. He talks about asking pharmacies to discount drugs, but not one word about physician's fees. Does he not realize that he and his greedy profession has been pricing themselves out of the market? What good is "quality medicine" if it is unaffordable? M. STEIN Sherman Oaks
July 28, 2003
Marijuana reduces pain and nausea while stimulating the appetite. This makes it an excellent medicine for certain types of diseases, a point the author of "A Haze of Misinformation Clouds Issue of Medical Marijuana" (Commentary, July 22) seems to miss entirely. What kinds of diseases are these? Cancer (especially the symptoms of chemotherapy) and AIDS are two of the most notable. No one claims that marijuana can "cure" these diseases. But shouldn't we allow victims of these maladies to live their final days in comfort?
May 21, 1999 |
Health officials in northeastern Cambodia made an urgent appeal for medicine to fight a cholera outbreak that has killed 61 people. Antibiotics and intravenous serum have been flown into Ratanakiri province from the capital, Phnom Penh, but provincial health advisor Dr. Gerry Pais said the supplies fall far short of the need. Nongovernmental organizations have been unable to provide enough assistance to meet the shortfall, he said.
June 30, 1985
As I follow the headlines each day informing me of how our noble politicians are protecting the people by demanding strict enforcement of the death penalty, and the same venal people are demanding the heads of certain judges, I am utterly dismayed. And as I read of the gross inequities in law practiced against women and minorities in the name of a peculiar doctrine termed "reverse discrimination," and when I hear of the further erosion of the Fourth Amendment by the gutting of the exclusionary rule, I am struck with the stark difference between the twisted path of the law and the broad avenue of medicine.
December 26, 1985 |
Healing the Wounds: A Physician Looks at His Work by David Hilfiker MD (Pantheon Books: $14.95). Though his autobiography often reads like a medical Western, we believe David Hilfiker when he says he began practicing medicine not for material gain but "to alleviate humanity's suffering." We quickly see how the demands of a general family practice in a rural clinic, located five hours from Duluth, Minn., began to erode his idealism.
CALIFORNIA | LOCAL
November 20, 1989 |
The British Medical Assn. has approved a game for schoolchildren with cards depicting condoms and sperm donation to teach children 11 to 18 about the dangers of AIDS. The game released last week consists of 28 cards depicting a range of social and sexual activities that children are asked to define as either safe or as posing a risk of transmitting acquired immune deficiency syndrome. Among the safe behaviors are shaking hands, kissing, sharing food, donating blood and coughing and sneezing.
November 4, 2007 |
Wyeth voluntarily recalled several Robitussin and Dimetapp cough and cold medicines whose measuring cups aren't marked for the proper dose for children ages 2 to 5. Products with a new cup marked for the recommended half-teaspoon dose are expected to be available at stores this month, the Madison, N.J.-based drug maker said.
December 28, 2002 |
Pfizer Inc.'s Relpax migraine medicine won Food and Drug Administration approval, giving the world's biggest drug maker a rival to treatments from GlaxoSmithKline, AstraZeneca and Merck & Co. Pfizer already sells Relpax in the United Kingdom, Japan, Italy and several other nations. The drug maker is attempting to enter a market in which GlaxoSmithKline's Imitrex migraine medicine has annual sales of more than $1 billion, about 75% of which is in the U.S.